biomedicina slovenica


re="Drug Metab Dispos" : 7

  1. Monostory K; Pascussi JM; Szabo P; Temesvari M; Kohalmy K; Ačimovič J; Kocjan D; Kuzman D; Wilzewski B; Bernhardt R; Kobori L; Rozman D
    Drug interaction potential of LK-935, the novel nonstatin-type cholesterol-lowering agent
    2009
  2. Ačimovič J; Korošec T; Seliškar M; Bjorkhem I; Monostory K; Szabo P; Pascussi JM; Belic A; Kocjan D; Urleb U; Rozman D
    Inhibition of human sterol delta 7-reductase and other post-lanosterol enzymes by 2-(4-phenethylpiperazin-1-yl)-1-(pyridine-3-yl)ethanol (LK-980), a novel inhibitor of cholesterol synthesis
    2011
  3. Bohanec-Grabar Petra; Grabnar Iztok; Rozman Blaž; Logar Dušan; Tomšič Matija; Šuput Daša; Trdan Tina; Peterlin-Mašič Lucija; Mrhar Aleš; Dolžan Vita
    Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis
    2009
  4. Monostory K; Pascussi JM; Szabo P; Temesvari M; Kohalmy K; Ačimovič J; Kocjan D; Kuzman D; Wilzewski B; Bernhardt R; Kobori L; Rozman D
    Drug-interaction potential of LK-935, the novel non-statin type cholesterol lowering agent
    2009
  5. Herman Darja; Dolžan Vita; Ingelman-Sundberg Magnus
    Characterization of the novel defective CYP2C9*24 allele
    2007
  6. Kohalmy K; Tamasi V; Kobori L; Sarvary E; Pascussi JM; Porrogi P; Rozman D; Prough RA; Meyer UA; Monostory K
    Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor
    2007
  7. Rozman Damjana; Waterman Michael R
    Anthony Y. H. Lu commemorative issue: lanosterol 14 alpha-demethylase (CYP51) and spermatogenesis
    1998


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko